MISOPROSTOL Gene Set

Dataset DGIdb Drug Targets 2026
Category physical interactions
Type drug
Description A diastereoisomeric mixture composed of approximately equal amounts of a double racemate of four of the sixteen possible diastereoisomers of methyl (13E)-11,16-dihydroxy-16-methyl-9-oxoprost-13-en-1-oate that is racemic prostaglandin E1 which is lacking the hydroxy group at position 15, but which has an additional hydroxy group at position 16. It is a synthetic prostaglandin E1 analogue, used in the treatment of gastric and duodenal ulcers. A weak abortifacient, it is also used for cervical ripening prior to surgical termination of pregnancy. The (11R,16S)-diastereoisomer is the pharmacologically active form. (Chemical Entities of Biological Interest Ontology, CHEBI_63610)
External Link https://dgidb.org/results?searchType=drug&searchTerms=MISOPROSTOL
Similar Terms
Downloads & Tools

Genes

7 interacting proteins for the MISOPROSTOL drug from theDGIdb Drug Targets 2026 dataset.

Symbol Name Standardized Value
PTGER3 prostaglandin E receptor 3 (subtype EP3) 1.00823
PTGIR prostaglandin I2 (prostacyclin) receptor (IP) 0.66721
ABCC4 ATP-binding cassette, sub-family C (CFTR/MRP), member 4 0.472607
SLCO1B1 solute carrier organic anion transporter family, member 1B1 0.186709
PTGER4 prostaglandin E receptor 4 (subtype EP4) 0.140032
PTGER2 prostaglandin E receptor 2 (subtype EP2), 53kDa 0.112861
NPSR1 neuropeptide S receptor 1 0.079597